Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

622 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Decoding triancestral origins, archaic introgression, and natural selection in the Japanese population by whole-genome sequencing.
Liu X, Koyama S, Tomizuka K, Takata S, Ishikawa Y, Ito S, Kosugi S, Suzuki K, Hikino K, Koido M, Koike Y, Horikoshi M, Gakuhari T, Ikegawa S, Matsuda K, Momozawa Y, Ito K, Kamatani Y, Terao C. Liu X, et al. Among authors: kosugi s. Sci Adv. 2024 Apr 19;10(16):eadi8419. doi: 10.1126/sciadv.adi8419. Epub 2024 Apr 17. Sci Adv. 2024. PMID: 38630824 Free PMC article.
Variant spectrum of von Hippel-Lindau disease and its genomic heterogeneity in Japan.
Tamura K, Kanazashi Y, Kawada C, Sekine Y, Maejima K, Ashida S, Karashima T, Kojima S, Parrish NF, Kosugi S, Terao C, Sasagawa S, Fujita M, Johnson TA, Momozawa Y, Inoue K, Shuin T, Nakagawa H. Tamura K, et al. Among authors: kosugi s. Hum Mol Genet. 2023 Jun 5;32(12):2046-2054. doi: 10.1093/hmg/ddad039. Hum Mol Genet. 2023. PMID: 36905328 Free PMC article.
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.
Shimazu Y, Kanda J, Onda Y, Fuchida SI, Ohta K, Shimura Y, Kosugi S, Yamamura R, Matsuda M, Hanamoto H, Adachi Y, Anzai N, Hotta M, Fukushima K, Yagi H, Yoshihara S, Tanaka Y, Takakuwa T, Tanaka H, Shibayama H, Uoshima N, Hosen N, Ito T, Shimazaki C, Matsumura I, Kuroda J, Takaori-Kondo A, Hino M. Shimazu Y, et al. Among authors: kosugi s. Cancer Immunol Immunother. 2024 May 17;73(7):135. doi: 10.1007/s00262-024-03711-8. Cancer Immunol Immunother. 2024. PMID: 38758239 Free PMC article.
Renal sinus fat is associated with intrarenal hemodynamic abnormalities independent of visceral fat in patients with chronic kidney disease.
Kaneko K, Mitsuno R, Kojima D, Azegami T, Kosugi S, Nakamura T, Hashiguchi A, Yamada Y, Jinzaki M, Yamaguchi S, Itoh H, Yoshino J, Hayashi K. Kaneko K, et al. Among authors: kosugi s. Obes Res Clin Pract. 2024 Mar-Apr;18(2):118-123. doi: 10.1016/j.orcp.2024.03.005. Epub 2024 Mar 29. Obes Res Clin Pract. 2024. PMID: 38555192
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016-2021).
Shibayama H, Itagaki M, Handa H, Yokoyama A, Saito A, Kosugi S, Ota S, Yoshimitsu M, Tanaka Y, Kurahashi S, Fuchida SI, Iino M, Shimizu T, Moriuchi Y, Toyama K, Mitani K, Tsukune Y, Kada A, Tamura H, Abe M, Iwasaki H, Kuroda J, Takamatsu H, Sunami K, Kizaki M, Ishida T, Saito T, Matsumura I, Akashi K, Iida S. Shibayama H, et al. Among authors: kosugi s. Int J Hematol. 2024 Mar 29. doi: 10.1007/s12185-024-03754-8. Online ahead of print. Int J Hematol. 2024. PMID: 38548963
Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study.
Nakamura N, Arima N, Takakuwa T, Yoshioka S, Imada K, Fukushima K, Hotta M, Fuchida SI, Kanda J, Uoshima N, Shimura Y, Tanaka H, Ohta K, Kosugi S, Yagi H, Yoshihara S, Yamamura R, Adachi Y, Hanamoto H, Shibayama H, Hosen N, Ito T, Shimazaki C, Takaori-Kondo A, Kuroda J, Matsumura I, Hino M; Kansai Myeloma Forum. Nakamura N, et al. Among authors: kosugi s. Ann Hematol. 2024 Mar 16. doi: 10.1007/s00277-024-05705-z. Online ahead of print. Ann Hematol. 2024. PMID: 38492020
622 results